SCHEMBL29630552

SCHEMBL29630552

N=C(N)NCCC[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CN)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ SLC15A2 Q16348 1/20 0.41
▸ FOLH1 Q04609 1/20 0.40
▸ GNPAT O15228 2/20 0.40
▸ NPY4R P50391 9/20 0.39
▸ NPY5R Q15761 8/20 0.39
▸ NPY1R P25929 7/20 0.39
▸ NPY2R P49146 5/20 0.39
▸ C3AR1 Q16581 1/20 0.39
▸ ECE1 P42892 2/20 0.38
▸ NOD1 Q9Y239 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29851173 1.00 SLC15A2 (0.41) SLC15A2FOLH1GNPATNPY4RNPY5R
SCHEMBL29839258 0.95 NPY4R (0.41) SLC15A2FOLH1NPY4RNPY5RNPY1R
SCHEMBL31064881 0.95 NPY4R (0.41) SLC15A2FOLH1NPY4RNPY5RNPY1R
SCHEMBL29485126 0.93 GNPAT (0.48) SLC15A2FOLH1GNPATNPY4RNPY5R
SCHEMBL29875467 0.92 SLC15A2 (0.44) SLC15A2GNPATNPY4RNPY5RNPY1R
SCHEMBL3952924 0.92 SLC15A2 (0.44) SLC15A2GNPATNPY4RNPY5RNPY1R
SCHEMBL3952951 0.92 SLC15A2 (0.44) SLC15A2GNPATNPY4RNPY5RNPY1R
SCHEMBL29875780 0.92 SLC15A2 (0.44) SLC15A2GNPATNPY4RNPY5RNPY1R
SCHEMBL29638080 0.91 NPY4R (0.43) FOLH1GNPATNPY4RNPY5RNPY1R
SCHEMBL29608915 0.91 NPY4R (0.43) SLC15A2FOLH1GNPATNPY4RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11807899-B2 Biochemical reaction methods and reagents comprising intrinsically disordered regions Biocrucible Limited 2023-11-07 — — US disclosed
US-20220145378-A1 BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS Biocrucible Limited (GB) 2022-05-12 — — US disclosed
Send feedback